http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
FRONTERA COMPLETES DIVESTMENT OF ITS COLOMBIAN E&P ASSETS PORTFOLIO TO PAREX RESOURCES; POSITIONS ITSELF AS A STANDALONE INFRASTRUCTURE COMPANY ANNOUNCES RETURN OF CAPITAL DISTRIBUTION TO SHAREHOL
-
FRONTERA BECOMES PURE-PLAY INFRASTRUCTURE COMPANY
-
Margaritaville & MRG Development Announce Margaritaville Vacation Suites Branson
-
Boomtown Casino & Hotel New Orleans Awards $20,000 Scholarship to Daughter of Nine-Year Team Member
-
PolyPid completes FDA submission for surgical infection prevention drug
-
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
-
American Resources Announces June Conference and Event Schedule
-
Greenwich LifeSciences presents FLAMINGO-01 immune response data
-
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
-
NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update
-
Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis
-
North Highland Names Anthony Shaw Global Chief Executive Officer
-
Phenomenex Launches Endrix Long Life Columns, Redefining Column Durability and Method Reliability
-
Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis
-
MAX Power Targets Next-Generation AI Infrastructure Powered by Natural Hydrogen Following Lawson Discovery
-
Toshiba Printer Tackles Industrial Labeling
-
Veracyte launches Prosigna breast cancer test in US market
-
TG Therapeutics publishes data showing BRIUMVI reduced MS relapses by 56.7%
-
TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology
-
Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.
-
Brixton Metals Drills 2.3 m of 1,811 g/t Silver within 27.7 m of 166.45 g/t Silver at its Langis Project
-
TTGI Subsidiary Claratti Expands CrewMate Lite Deployment to 69 Units Across Australia in Partnership with Seafarer Connect and the Tas Bull Seafarers Foundation
-
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
-
Greenwich LifeSciences delays Form 10-K filing due to auditor coordination
-
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
-
ASUS Republic of Gamers Unveils ROG G1000 Edition 20 Desktop and ROG Xbox Ally X20 Bundle at Computex 2026
-
APEMARS Pushes Launch Narrative With Bonus-Driven Scarcity and $12K Turning Into $122K While Cheems and Snek Remain Relevant
-
Market News Today: Insiders Predict 1000X For APEMARS Presale Shooting Past PENGU and FARTCOIN as the Top Altcoin to Invest in
-
Edge Total Intelligence Reports Q1 2026 Revenue Growth of 121% Year-over-Year and 211% Sequentially and Rapidly Commercializes Acquired Austal Maritime and Aviation Defense Technology
-
Bitget Tackles Trading Burnout in New UEX Video Series
-
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
-
APEMARS Presale Selling Out Fast this May, Outrunning Top Altcoin Picks Like BCH and BTC – Secure Tokens Now
-
Top Crypto to Buy in 2026? APEMARS Sparks 916% ROI Surge With LAUNCH350 Bonus Offer As BNB News Momentum And Stellar Growth Trends
-
Turn $1K Into $35K: APEMARS Emerging Among Top Crypto Coins Over RateX And XRP Price Prediction – Stage 23 Offers ROI
-
Skipped Early Rewards From Zcash and BNB? Grab APEMARS With 350% Extra Bonus in its Presale – The Top 100X Crypto to Buy in May
-
Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
-
Solana Unchained Outlines Fixed-Supply Utility Architecture and AI Tool Hub Ahead of Late May Public Allocation Launch
-
Whale Alert: 7 Top Crypto Coins in 2026 Becoming Harder for Traders to Ignore With APEMARS’ High Value Presale Closing
-
National Champions are Honoured at the Closing Ceremony of the Skills Canada National Competition 2026, in Toronto
-
AdvisorVault Adds Social Media Archiving to its Consolidated D3P Service
-
Top 12 Million Dollar Narrative Coins Sending Ripples Across Crypto With APEMARS Presale Ready for Takeoff this May
-
Top Coins Alert: Bitcoin Cash, and XRP Soar, While APEMARS Enter The Best Altcoins to Invest Narrative
-
Mineralys presents lorundrostat data for hypertension patients with kidney disease
-
Mineralys presents positive chronic kidney disease data for lorundrostat
-
Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiova
-
9 Best Cryptos To Buy Today: APEMARS Storms Ahead With 1039% ROI Potential and LAUNCH350 Bonus Rewards
-
Exelixis reports Cabometyx trial results for neuroendocrine tumors
-
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
-
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
-
Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
